Abstract
Summary
The global Forensic Genomics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
Forensic DNA databases, which store DNA profiles of individuals convicted of crimes or collected from crime scenes, are expanding globally. These databases serve as valuable resources for cross-referencing DNA profiles, identifying suspects, and generating investigative leads. The growth of these databases has increased the demand for DNA analysis and database management solutions.
Forensic genomics, also known as forensic genetics or forensic DNA analysis, is a field of forensic science that utilizes genetic information, particularly DNA analysis, to assist in criminal investigations, identify individuals, establish biological relationships, and provide evidence in legal proceedings. It combines principles of genetics, molecular biology, and forensic science to analyze and interpret DNA evidence collected from crime scenes, victims, suspects, and other relevant sources.
LPI (LP Information)' newest research report, the “Forensic Genomics Industry Forecast” looks at past sales and reviews total world Forensic Genomics sales in 2022, providing a comprehensive analysis by region and market sector of projected Forensic Genomics sales for 2023 through 2029. With Forensic Genomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Forensic Genomics industry.
This Insight Report provides a comprehensive analysis of the global Forensic Genomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Forensic Genomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Forensic Genomics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Forensic Genomics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Forensic Genomics.
This report presents a comprehensive overview, market shares, and growth opportunities of Forensic Genomics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Capillary Electrophoresis
Next-generation Sequencing
PCR Amplification
Segmentation by application
Criminal Testing
Paternity & Familial Testing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
Eurofins Discovery
Gene by Gene, Ltd.
Verogen, Inc.
Illumina, Inc.
Neogen Corp.
Forensic DNA databases, which store DNA profiles of individuals convicted of crimes or collected from crime scenes, are expanding globally. These databases serve as valuable resources for cross-referencing DNA profiles, identifying suspects, and generating investigative leads. The growth of these databases has increased the demand for DNA analysis and database management solutions.
Forensic genomics, also known as forensic genetics or forensic DNA analysis, is a field of forensic science that utilizes genetic information, particularly DNA analysis, to assist in criminal investigations, identify individuals, establish biological relationships, and provide evidence in legal proceedings. It combines principles of genetics, molecular biology, and forensic science to analyze and interpret DNA evidence collected from crime scenes, victims, suspects, and other relevant sources.
LPI (LP Information)' newest research report, the “Forensic Genomics Industry Forecast” looks at past sales and reviews total world Forensic Genomics sales in 2022, providing a comprehensive analysis by region and market sector of projected Forensic Genomics sales for 2023 through 2029. With Forensic Genomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Forensic Genomics industry.
This Insight Report provides a comprehensive analysis of the global Forensic Genomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Forensic Genomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Forensic Genomics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Forensic Genomics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Forensic Genomics.
This report presents a comprehensive overview, market shares, and growth opportunities of Forensic Genomics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Capillary Electrophoresis
Next-generation Sequencing
PCR Amplification
Segmentation by application
Criminal Testing
Paternity & Familial Testing
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE Healthcare
Thermo Fisher Scientific, Inc.
Agilent Technologies, Inc.
Eurofins Discovery
Gene by Gene, Ltd.
Verogen, Inc.
Illumina, Inc.
Neogen Corp.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Forensic Genomics Market Size 2018-2029
2.1.2 Forensic Genomics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Forensic Genomics Segment by Type
2.2.1 Capillary Electrophoresis
2.2.2 Next-generation Sequencing
2.2.3 PCR Amplification
2.3 Forensic Genomics Market Size by Type
2.3.1 Forensic Genomics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Forensic Genomics Market Size Market Share by Type (2018-2023)
2.4 Forensic Genomics Segment by Application
2.4.1 Criminal Testing
2.4.2 Paternity & Familial Testing
2.4.3 Others
2.5 Forensic Genomics Market Size by Application
2.5.1 Forensic Genomics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Forensic Genomics Market Size Market Share by Application (2018-2023)
3 Forensic Genomics Market Size by Player
3.1 Forensic Genomics Market Size Market Share by Players
3.1.1 Global Forensic Genomics Revenue by Players (2018-2023)
3.1.2 Global Forensic Genomics Revenue Market Share by Players (2018-2023)
3.2 Global Forensic Genomics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Forensic Genomics by Regions
4.1 Forensic Genomics Market Size by Regions (2018-2023)
4.2 Americas Forensic Genomics Market Size Growth (2018-2023)
4.3 APAC Forensic Genomics Market Size Growth (2018-2023)
4.4 Europe Forensic Genomics Market Size Growth (2018-2023)
4.5 Middle East & Africa Forensic Genomics Market Size Growth (2018-2023)
5 Americas
5.1 Americas Forensic Genomics Market Size by Country (2018-2023)
5.2 Americas Forensic Genomics Market Size by Type (2018-2023)
5.3 Americas Forensic Genomics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Forensic Genomics Market Size by Region (2018-2023)
6.2 APAC Forensic Genomics Market Size by Type (2018-2023)
6.3 APAC Forensic Genomics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Forensic Genomics by Country (2018-2023)
7.2 Europe Forensic Genomics Market Size by Type (2018-2023)
7.3 Europe Forensic Genomics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Forensic Genomics by Region (2018-2023)
8.2 Middle East & Africa Forensic Genomics Market Size by Type (2018-2023)
8.3 Middle East & Africa Forensic Genomics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Forensic Genomics Market Forecast
10.1 Global Forensic Genomics Forecast by Regions (2024-2029)
10.1.1 Global Forensic Genomics Forecast by Regions (2024-2029)
10.1.2 Americas Forensic Genomics Forecast
10.1.3 APAC Forensic Genomics Forecast
10.1.4 Europe Forensic Genomics Forecast
10.1.5 Middle East & Africa Forensic Genomics Forecast
10.2 Americas Forensic Genomics Forecast by Country (2024-2029)
10.2.1 United States Forensic Genomics Market Forecast
10.2.2 Canada Forensic Genomics Market Forecast
10.2.3 Mexico Forensic Genomics Market Forecast
10.2.4 Brazil Forensic Genomics Market Forecast
10.3 APAC Forensic Genomics Forecast by Region (2024-2029)
10.3.1 China Forensic Genomics Market Forecast
10.3.2 Japan Forensic Genomics Market Forecast
10.3.3 Korea Forensic Genomics Market Forecast
10.3.4 Southeast Asia Forensic Genomics Market Forecast
10.3.5 India Forensic Genomics Market Forecast
10.3.6 Australia Forensic Genomics Market Forecast
10.4 Europe Forensic Genomics Forecast by Country (2024-2029)
10.4.1 Germany Forensic Genomics Market Forecast
10.4.2 France Forensic Genomics Market Forecast
10.4.3 UK Forensic Genomics Market Forecast
10.4.4 Italy Forensic Genomics Market Forecast
10.4.5 Russia Forensic Genomics Market Forecast
10.5 Middle East & Africa Forensic Genomics Forecast by Region (2024-2029)
10.5.1 Egypt Forensic Genomics Market Forecast
10.5.2 South Africa Forensic Genomics Market Forecast
10.5.3 Israel Forensic Genomics Market Forecast
10.5.4 Turkey Forensic Genomics Market Forecast
10.5.5 GCC Countries Forensic Genomics Market Forecast
10.6 Global Forensic Genomics Forecast by Type (2024-2029)
10.7 Global Forensic Genomics Forecast by Application (2024-2029)
11 Key Players Analysis
11.1 GE Healthcare
11.1.1 GE Healthcare Company Information
11.1.2 GE Healthcare Forensic Genomics Product Offered
11.1.3 GE Healthcare Forensic Genomics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 GE Healthcare Main Business Overview
11.1.5 GE Healthcare Latest Developments
11.2 Thermo Fisher Scientific, Inc.
11.2.1 Thermo Fisher Scientific, Inc. Company Information
11.2.2 Thermo Fisher Scientific, Inc. Forensic Genomics Product Offered
11.2.3 Thermo Fisher Scientific, Inc. Forensic Genomics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.2.5 Thermo Fisher Scientific, Inc. Latest Developments
11.3 Agilent Technologies, Inc.
11.3.1 Agilent Technologies, Inc. Company Information
11.3.2 Agilent Technologies, Inc. Forensic Genomics Product Offered
11.3.3 Agilent Technologies, Inc. Forensic Genomics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Agilent Technologies, Inc. Main Business Overview
11.3.5 Agilent Technologies, Inc. Latest Developments
11.4 Eurofins Discovery
11.4.1 Eurofins Discovery Company Information
11.4.2 Eurofins Discovery Forensic Genomics Product Offered
11.4.3 Eurofins Discovery Forensic Genomics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Eurofins Discovery Main Business Overview
11.4.5 Eurofins Discovery Latest Developments
11.5 Gene by Gene, Ltd.
11.5.1 Gene by Gene, Ltd. Company Information
11.5.2 Gene by Gene, Ltd. Forensic Genomics Product Offered
11.5.3 Gene by Gene, Ltd. Forensic Genomics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Gene by Gene, Ltd. Main Business Overview
11.5.5 Gene by Gene, Ltd. Latest Developments
11.6 Verogen, Inc.
11.6.1 Verogen, Inc. Company Information
11.6.2 Verogen, Inc. Forensic Genomics Product Offered
11.6.3 Verogen, Inc. Forensic Genomics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Verogen, Inc. Main Business Overview
11.6.5 Verogen, Inc. Latest Developments
11.7 Illumina, Inc.
11.7.1 Illumina, Inc. Company Information
11.7.2 Illumina, Inc. Forensic Genomics Product Offered
11.7.3 Illumina, Inc. Forensic Genomics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 Illumina, Inc. Main Business Overview
11.7.5 Illumina, Inc. Latest Developments
11.8 Neogen Corp.
11.8.1 Neogen Corp. Company Information
11.8.2 Neogen Corp. Forensic Genomics Product Offered
11.8.3 Neogen Corp. Forensic Genomics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Neogen Corp. Main Business Overview
11.8.5 Neogen Corp. Latest Developments
12 Research Findings and Conclusion